JG
Julia P Gregory
Director

Julia P Gregory insider trades: Nurix Therapeutics (NRIX) stock buys and sales

Director, Nurix Therapeutics Last trade Oct 14, 2026 30 Form 4 filings
$529K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2006
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Julia reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 14, 2026NRIX↓ Sell$529K
Oct 25, 2022BHVN↑ Buy$100K
Dec 20, 2021BHVN↓ Sell$1.5M
Nov 22, 2019BHVN↓ Sell$657K
Feb 21, 2019BHVN↓ Sell$523K
Mar 2, 2015CFRX↑ Buy$54K
Jan 4, 2006LEXG↓ Sell$41K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NRIX insiders

Open-market trades in the last 12 months

About Julia P Gregory's insider trades

Julia P Gregory is a director at Nurix Therapeutics (NRIX). Since Jan 4, 2006, Julia has reported 2 open-market purchases worth $154K and 5 sales worth $3.2M on SEC Form 4. In the last 12 months: 1 sale ($529K).

Their filings also include grants and awards (21 filings), option exercises (6 filings), other transactions (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.